MedPath

Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment

Recruiting
Conditions
COVID-19
Registration Number
NCT05359159
Lead Sponsor
University of L'Aquila
Brief Summary

People affected by SARS-CoV-2 infection, whether patients have developed mild forms or a severe form of the disease, complain of nonspecific and entirely new symptoms or complain about the persistence pf them.Investigators intend to follow over time the post-infectious phase of patients discharged from sub-intensive care unit. The aim is to identify symptoms and their frequency of presentation in the SARS-CoV-2 population in the post-acute period.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients over 18
Exclusion Criteria
  • Patients under 18

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Greater understanding of SARS-CoV-2 disease24 months

Greater understanding of SARS-CoV-2 disease and its long-term manifestations. To this end, the clinical manifestations, any alterations in laboratory and instrumental parameters will be evaluated to identify organ damages and calculate its prevalence

Secondary Outcome Measures
NameTimeMethod
Measurement of psychological impact of SARS-CoV-2 disease24 months

Understanding the impact of the disease and its sequelae on daily life and the impact on the psychological aspect of the person;

Trial Locations

Locations (2)

Clara Balsano

🇮🇹

L'Aquila, Italy/L'Aquila, Italy

University of L'Aquila

🇮🇹

L'Aquila, Italy

Clara Balsano
🇮🇹L'Aquila, Italy/L'Aquila, Italy
Clara Balsano
Contact
+390862434774
clara.balsano@univaq.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.